CITIGROUP INC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$554,579
-2.2%
61,895
+22.8%
0.00%
Q2 2023$566,854
+1007.0%
50,387
+1033.6%
0.00%
Q1 2023$51,206
-56.6%
4,445
-56.3%
0.00%
Q4 2022$117,859
-92.7%
10,169
-92.0%
0.00%
-100.0%
Q3 2022$1,608,000
-41.9%
126,578
-68.6%
0.00%
-50.0%
Q2 2022$2,766,000
+3741.7%
402,656
+5322.2%
0.00%
Q1 2022$72,000
-56.4%
7,426
-46.6%
0.00%
Q4 2021$165,000
+166.1%
13,919
+267.2%
0.00%
Q3 2021$62,000
+55.0%
3,791
+101.9%
0.00%
Q2 2021$40,000
+135.3%
1,878
+75.8%
0.00%
Q1 2021$17,000
-69.6%
1,068
-59.8%
0.00%
Q4 2020$56,0002,6590.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,960,046$28,535,00016.60%
MPM ASSET MANAGEMENT LLC 4,951,303$47,731,00016.31%
Atlas Venture Life Science Advisors, LLC 8,934,902$86,132,00010.89%
Logos Global Management LP 2,734,392$26,360,0003.42%
Deep Track Capital, LP 3,500,000$33,740,0002.16%
Octagon Capital Advisors LP 525,284$5,064,0001.10%
HighVista Strategies LLC 168,691$1,626,0001.03%
Monashee Investment Management LLC 279,704$2,696,0000.78%
COMMODORE CAPITAL LP 305,125$2,941,0000.66%
RA Capital Management 2,805,045$27,041,0000.59%
View complete list of DYNE THERAPEUTICS INC shareholders